Bayesian Calibration of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Carbaryl Cholinesterase Inhibition

By Nong Andy   Tan Yu-Mei   Krolski Michael   Wang Jiansuo   Lunchick Curt   Conolly Rory   Clewell Harvey  

Journal of Toxicology and Environmental Health, Vol. 71, Iss. 20, 2008-01 ,pp. : 1363-1381

Taylor & Francis Ltd

Access to resources Recommend Favorite

Ubiquity: a framework for physiological/mechanism-based pharmacokinetic/pharmacodynamic model development and deployment

By Harrold John   Abraham Anson  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 141-151

Springer Publishing Company

Access to resources Recommend Favorite

A Pharmacokinetic–Pharmacodynamic Model of Chemotherapy of Human Immunodeficiency Virus Infection that Relates Development of Drug Resistance to Treatment Intensity

By Jackson Robert C.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 713-730

Springer Publishing Company

Access to resources Recommend Favorite

An integrated pharmacokinetic–pharmacodynamic model for an Aurora kinase inhibitor

By Kamei Hiroko   Jackson Robert   Zheleva Daniella   Davidson Fordyce  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 407-434

Springer Publishing Company

Access to resources Recommend Favorite

Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting

By Sasaki Tomohiro   Tabuchi Hiroko   Higuchi Shun   Ieiri Ichiro  

Pharmacogenomics, Vol. 10, Iss. 8, 2009-08 ,pp. : 1257-1266

Future Medicine

Access to resources Recommend Favorite